Analysts at JP Morgan (JPM) downgraded Chimerix, Inc. (CMRX) from ‘Overweight’ to ‘Neutral’ in a research report issued to clients on Tuesday. The target price for CMRX is lowered from $65 to $15. The name was also downgraded to ‘Market Perform’ at William Blair. Chimerix Inc. rose $0.42 to $7.04 in recent trading. Shares of […]
View the full post at: Notable Downgrades: Chimerix (CMRX), Covanta Holding Corp (CVA), NetApp (NTAP)